Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril for Cardiovascular Protection After Preeclampsia
NCT07222852Phase 3Recruiting
- Sponsor
- Women & Infants Hospital
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril in hypertensive disorder of pregnancy (HDP), sponsored by Women & Infants Hospital. Started Jan 2026; status: recruiting.
02
Drugs
enalapril
03
Conditions
hypertensive disorder of pregnancy (HDP)
Beyond the preview
Go deeper on NCT07222852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222852.